Depression is frequent in older individuals and is often associated with cognitive impairment
and increasing risk of subsequent dementia. Late-life depression (LLD) has a negative …

Major depressive disorder is among the most prevalent psychiatric disorders, exacting a
substantial personal, social, and economic toll. Antidepressant treatment typically involves …

Objectives Previous studies suggest that major depressive disorder (MDD) may be
associated with volumetric indications of accelerated brain aging. This study investigated …

The study investigates morphometric changes using surface-based measures and logistic
regression in Major depressive-disorder (MDD) and Manic-disorder patients as compared to …

The number of patients suffering from major depressive disorder (MDD) is increasing
worldwide. Imbalanced hemispherical brain activity may be an underlying factor of MDD; …

The neurobiology of autism has been shown to involve alterations in cortical morphology
and gamma‐aminobutyric acid A (GABAA) receptor density. We hypothesized that GABAA …

Dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis is considered one of the
mechanisms underlying the development of major depressive disorder (MDD), but the exact …

Objective Major depression disorder (MDD) is a harmful disorder, and the pathological
mechanism remains unclear. The primary pharmacotherapy regimen for MDD is selective …

Electroconvulsive therapy (ECT) is a highly effective treatment for depression. Previous
studies point to ECT-induced volume increase in the hippocampi and amygdalae, and to …

Background Major depressive disorder (MDD) and schizophrenia (SCZ) are heritable brain
disorders characterized by alterations in cortical thickness. However, the shared genetic …